Lung Complications After Hemotopoietic Cell Transplant

Lung Complications After Hemotopoietic Cell Transplant

Regular price
Sale price
Sold out
Unit price




Lung complications after hematopoietic cell transplant are common and often occur insidiously, leading to morbidity and mortality despite curing high-risk hematologic malignancies. This session will refresh attendees on the natural history of lung complications, update viewers on the safety of azithromycin after transplant, and highlight state-of-the-art advances in the detection of occult infections, novel thoracic imaging modalities, and cloud-based home spirometry platforms to detect and halt the progression of pulmonary diseases such as bronchiolitis obliterans. The session will conclude with cutting-edge treatments for steroid-refractory graft-versus-host disease of the lung, offering new options for those who care for patients with lung disease after hematopoietic transplant. 

CME credits and/or Certificates of Completion are not provided for this session.

1- Better recognize and diagnose early lung complications after hematopoietic cell transplant, including bronchiolitis obliterans syndrome

2- Define new strategies to identify patients at high risk for developing lung complications after hematopoietic cell transplant

3- Integrate new options for the treatment of steroid-refractory lung disease after hematopoietic cell transplant

Guang-Shing Cheng, MD: Lung Complications After HCT: Where Do We Stand in 2021?

David Noel O'Dwyer, BM, BCH, BMedSci, PhD: Dysbiosis and Occult Viral Infections: Silent Instigators of Lung Disease

Jason C. Woods, PhD: Imaging the Lung with 20/20 Vision: Early Indicators of Lung Impairment

Ajay Sheshadri, MD, BA, MSCR: Bringing It Back Home: Early Detection with Home Spirometry Telemonitoring

Anne Bergeron, MD, PhD, APHP: ALLOZITHRO and Beyond: Reassessing the Safety of Azithromycin After Allogeneic HCT

Joe L. Hsu, MD, MPH: Beyond Steroids: New Targets to Treat BOS and Other Late Lung Complications

You can save 20% today by joining the ATS. Join more than 16,000 healthcare providers and researchers as a member of the American Thoracic Society today. As an ATS member, you’ll gain access to cutting-edge science, collaboration opportunities, discounts on the annual ATS International Conference, and resources to share with patients. The ATS offers multiple ways to get involved, from Assembly membership to in-person networking opportunities, as well as an online community offered through DocMatter. Join the ATS Today!